Pat Dorsey's RPRX Position Overview
Pat Dorsey (via Dorsey Asset Management, LLC) currently holds 2.28 M shares of Royalty Pharma plc (RPRX) worth $109.21 M, representing 8.70% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Pat Dorsey has maintained this position in RPRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 17,101 shares. Largest reduction occurred in Q4 2025, reducing 90,980 shares.
Analysis based on 13F filings available since 2013 Q2
Pat Dorsey's Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Pat Dorsey
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +17,101 | Add 0.76% | 2.28 M | $47.97 |
| Q4 2025 | -90,980 | Reduce 3.87% | 2.26 M | $38.64 |
| Q3 2025 | +2.35 M | New Buy | 2.35 M | $35.28 |
Pat Dorsey's Royalty Pharma plc Investment FAQs
Pat Dorsey first purchased Royalty Pharma plc (RPRX) in Q3 2025, acquiring 2,350,449 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Pat Dorsey has held Royalty Pharma plc (RPRX) for 3 quarters since Q3 2025.
Pat Dorsey's largest addition to Royalty Pharma plc (RPRX) was in Q3 2025, adding 2,350,449 shares worth $82.92 M.
According to the latest 13F filing for Q1 2026, Pat Dorsey's firm, Dorsey Asset Management, LLC, owns 2,276,570 shares of Royalty Pharma plc (RPRX), valued at approximately $109.21 M.
As of the Q1 2026 filing, Royalty Pharma plc (RPRX) represents approximately 8.70% of Pat Dorsey's publicly disclosed stock portfolio, making it one of their key holdings.
Pat Dorsey's peak holding in Royalty Pharma plc (RPRX) was 2,350,449 shares, as reported at the end of Q3 2025.